GBX Events

We Are Committed To Help Organisations Advance

The Mission

We Are Committed

Raison d'être

Since 2007

GBX Events researches and produces some of the world's top elite business to business partnering programmes in progressive industry sectors. We are obsessed with advancing you're why’s.

GBX was created based on a simple vision and mission. To create a high-level gathering dedicated to facing our customer's needs head-on but in an environment designed to take action.

For over two decades our team have been committed to providing the best possible platforms that offer advance learning, consultive networking and business culture transformation. This is what we do and we always strive to evolve and adapt to do better.

Advisory

The Why?

Why Partner With Us?

Networking Purists

We have seen this industry grow, adapt, evolve. Today, for the leaders we serve, we still keep our networking in its purest form. Personal contact. Whether it's sitting with a client or speaking over the phone we begin with customers about their pain points, we don’t ask them what to do. we isolate, get feedback, listen and adjust.

Less Is More, Not Quantity

Exceptional care is taken to ensure that each attendee is selected for their relevance, influence and seniority in the industry. Imagine no headhunters, no press, no interns, instead, it’s a meeting of the leading executives that possess incredible influence and authority.

Focus on Challenges Not Pitches

All presentations go through a rigorous revision process to ensure they are engaging, informative and with data that

can be transformed into actionable results.

Events

13th Annual Drug Discovery to Development Innovation Forum 2020

Visualising The Future

Discovery to Development Innovation Foru

Advisory

Proud to bring inspirational leaders from across the globe

Dr. Ted Torphy brings to BioMotiv over 30 years of experience in the pharmaceutical industry with a successful record in both small-molecule and large-molecule drug discovery and preclinical development. In addition to his role with BioMotiv, he is a member of the Innovation Support Center of the Harrington Discovery Institute and Board Chairman, Cystic Fibrosis Therapeutics, Inc. Ted also serves on the Board of Directors of several additional for-profit and non-profit organizations.

Patrick Basanez

Director
GBX Group

An accomplished professional with up to 15 years of industry experience of which over ten years focused on senior management experience.

He can create, manage and execute winning strategies, but most importantly he can translate some of the most complex action plans into a language understood by every degree of the business involved.

Patrick manages a team of up to 20 professionals, producing bespoke projects and premiership events in the pharmaceutical, outsourcing, and manufacturing markets. His approach is hands-on, he motivates, trains, and provides collaborative guidance to ensure hard work and dedication transforms into successful results.

His role involves the entire spectrum of corporate planning & business development, including implementing strategic directions, market research, value-added services, commercialisation and sales profitability.

Merck Millipore R&D Head

Prof. Dr. Thomas Herget is currently Head of Processing Technologies within the Merck Millipore process solutions division of Merck KGaA, where he develops new methods and materials for bioprocessing. He is also a medical professor at the University of Mainz and a biochemistry professor at the TU Darmstadt. He has received several awards, submitted 25 patents and authored more than 50 peer-reviewed papers. From 2004-2010, Prof. Dr. Thomas Herget served as the Director, New Technology Evaluation within Merck KGaA’s Chemicals R&D division. In that role, he ran laboratories in Darmstadt (Germany) and oversaw the R&D activities of Novagen (Madison) and Calbiochem (San Diego).

Dorothee Ambrosius

Head of Biologicals Strategy

Boehringer Ingelheim

Dorothee joined the leadership team of Boehringer Ingelheim on October 1, 2010 as Senior Vice President, Global Process Science. Her knowledge and over 20 years experience in research and development of Biopharmaceuticals has enabled her to serve as an asset to the organization as she leads the Process Science organization globally.

Director, Outreach & Partnerships, Center for Supply Chain Innovation, Texas Christian University Neeley School of Business

Dave Malenfant is Director, Outreach & Partnerships, Center for Supply Chain Innovation, at the Texas Christian University Neeley School of Business in Fort Worth, TX. He has more than 25 years of experience in driving change and performance improvement across the supply chain, and now builds partnerships with the Center and TCU Supply Chain through outreach with the business, academic, and association communities. He also serves as Executive Vice President, Industry Liaison and Talent Development, for the Biotech Supply Management Alliance. He holds a BA in Economics and Political Science from the University of Windsor in Canada.

Partners

Our Journey

RSVP

RSVP for our next event. See you soon!

GBX EVENTS